Literature DB >> 464580

Antimicrobial susceptibilities of rough, smooth, and mucoid colony types of Pseudomonas isolated from cystic fibrosis patients.

B A Maybury, J Blessing-Moore, S A deWit, N J Lewiston, A S Yeager.   

Abstract

Minimal inhibitory concentrations of carbenicillin, chloramphenicol, tetracycline, gentamicin, tobramycin, and trimethoprim-sulfamethoxazole were determined for rough, smooth, and mucoid Pseudomonas sp. isolates from sputa collected from 40 cystic fibrosis patients. Ninety-four percent of the minimal inhibitory concentrations obtained by using mixed inocula of colonies of different morphological types fell within one serial dilution of the most resistant minimal inhibitory concentration obtained when each colony type was tested separately.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 464580      PMCID： PMC352693          DOI： 10.1128/AAC.15.3.494

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  A microdilution method for antibiotic susceptibility testing: an evaluation.

Authors:  T L Gavan; M A Town
Journal:  Am J Clin Pathol       Date:  1970-06       Impact factor: 2.493

2.  Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study.

Authors:  A L Barry; R N Jones; T L Gavan
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

4.  Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.

Authors:  T Bergan; N Hoiby
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1975-12

5.  Dissociation in Pseudomonas aeruginosa.

Authors:  C H Zierdt; P J Schmidt
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

6.  Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.

Authors:  N Hoiby; E W Flensborg; B Beck; B Friis; S V Jacobsen; L Jacobsen
Journal:  Scand J Respir Dis       Date:  1977-04

7.  Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.

Authors:  R G Doggett; G M Harrison
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441
  7 in total
  4 in total

1.  Mixed-morphotype broth microdilution susceptibility testing of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  K G Van Horn
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

2.  Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.

Authors:  L Saiman; J L Burns; S Whittier; J Krzewinski; S A Marshall; R N Jones
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 3.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Accuracy and cost of antibiotic susceptibility testing of mixed morphotypes of Pseudomonas aeruginosa.

Authors:  G L Morlin; D L Hedges; A L Smith; J L Burns
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.